OLANZAPINE AND SAMIDORPHAN L-MALATE

OLANZAPINE AND SAMIDORPHAN L-MALATE was reported 1687 times

OLANZAPINE AND SAMIDORPHAN L-MALATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SCATOLIA 1 0.0588
1 ANAESTHESIA PROCEDURE 1 0.0526
2 ACUTE OESOPHAGEAL MUCOSAL LESION 2 0.0364
3 WAIST CIRCUMFERENCE DECREASED 1 0.0244
4 FALLOPIAN TUBE CANCER 2 0.0139
5 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0135
6 DRUG SCREEN FALSE POSITIVE 37 0.0134
7 OVERWORK 1 0.0128
8 EXPOSURE TO FUNGUS 2 0.0093
9 TOBACCO INTERACTION 1 0.0090
10 BINGE DRINKING 1 0.0088
11 HYPNOPOMPIC HALLUCINATION 1 0.0081
12 FEAR-RELATED AVOIDANCE OF ACTIVITIES 1 0.0066
13 RESTLESS ARM SYNDROME 1 0.0064
14 SUBSTANCE USE 10 0.0064
15 PROSOPAGNOSIA 1 0.0063
16 CONFUSIONAL AROUSAL 1 0.0062
17 OESOPHAGOGASTRIC FUNDOPLASTY 1 0.0059
18 PSEUDOSTROKE 2 0.0058
19 BLOOD LACTIC ACID DECREASED 1 0.0058
20 ATHETOSIS 1 0.0057
21 OESOPHAGEAL INJURY 2 0.0052
22 PSYCHIATRIC DECOMPENSATION 10 0.0051
23 CONTRAINDICATED PRODUCT ADMINISTERED 139 0.0046
24 INCREASED NEED FOR SLEEP 1 0.0043
25 NEGLECT OF PERSONAL APPEARANCE 1 0.0041
26 METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS 1 0.0039
27 VICTIM OF SEXUAL ABUSE 2 0.0038
28 AUTOSCOPY 2 0.0037
29 VICTIM OF ABUSE 1 0.0037
30 DEJA VU 1 0.0036
31 CLINODACTYLY 1 0.0036
32 HYPNAGOGIC HALLUCINATION 1 0.0033
33 TONGUE SPASM 1 0.0032
34 ACTIVITIES OF DAILY LIVING DECREASED 2 0.0031
35 DUPLICATE THERAPY ERROR 1 0.0031
36 EXTRAOCULAR MUSCLE DISORDER 1 0.0031
37 DREAMY STATE 1 0.0031
38 DRUG SCREEN POSITIVE 24 0.0030
39 FEMALE ORGASMIC DISORDER 1 0.0030
40 DRUG EFFECT FASTER THAN EXPECTED 1 0.0030
41 BINGE EATING 3 0.0028
42 OESOPHAGEAL MOTILITY DISORDER 1 0.0028
43 TRANCE 1 0.0027
44 ALLERGIC COUGH 2 0.0026
45 FLAT AFFECT 6 0.0026
46 ANHIDROSIS 1 0.0025
47 DELUSIONAL PERCEPTION 1 0.0024
48 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 1 0.0023
49 TONGUE MOVEMENT DISTURBANCE 2 0.0023
50 SEDATION 56 0.0021
51 SALIVARY GLAND DISORDER 1 0.0021
52 HYPERVIGILANCE 2 0.0021
53 SLEEP PARALYSIS 3 0.0020
54 HEAT STROKE 3 0.0020
55 DIABETIC RETINAL OEDEMA 1 0.0020
56 POOR PERSONAL HYGIENE 1 0.0019
57 PSYCHOTIC SYMPTOM 4 0.0019
58 ORTHOPAEDIC PROCEDURE 1 0.0019
59 BLOOD INSULIN INCREASED 1 0.0018
60 IRREGULAR BREATHING 1 0.0017
61 DRUG SCREEN NEGATIVE 3 0.0017
62 EUPHORIC MOOD 17 0.0017
63 HYPERSOMNIA 46 0.0016
64 FRACTURED COCCYX 2 0.0016
65 LIBIDO DISORDER 2 0.0015
66 SHORT-BOWEL SYNDROME 1 0.0015
67 OESOPHAGEAL HAEMORRHAGE 2 0.0015
68 HALLUCINATION, TACTILE 1 0.0015
69 CLUSTER HEADACHE 2 0.0015
70 FEELING OF RELAXATION 1 0.0015
71 CORNEAL ABRASION 2 0.0015
72 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
73 TEMPERATURE REGULATION DISORDER 3 0.0013
74 HALLUCINATION, AUDITORY 21 0.0013
75 CREATINE KINASE INCREASED 1 0.0013
76 PROCEDURAL NAUSEA 1 0.0012
77 MANIA 20 0.0012
78 SEIZURE CLUSTER 1 0.0012
79 ENERGY INCREASED 7 0.0012
80 SEDATION COMPLICATION 3 0.0012
81 MALIGNANT HYPERTENSION 1 0.0012
82 GENITAL BURNING SENSATION 1 0.0012
83 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
84 SELF-DESTRUCTIVE BEHAVIOUR 1 0.0011
85 EMOTIONAL POVERTY 2 0.0011
86 DYSPHEMIA 5 0.0011
87 HANGOVER 4 0.0011
88 CLUMSINESS 3 0.0011
89 COLOUR BLINDNESS 1 0.0011
90 DISTURBANCE IN SEXUAL AROUSAL 1 0.0011
91 SLEEP-RELATED EATING DISORDER 1 0.0011
92 THERAPEUTIC RESPONSE INCREASED 1 0.0011
93 STEREOTYPY 1 0.0011
94 PULPITIS DENTAL 1 0.0011
95 MECHANICAL VENTILATION 2 0.0011
96 FACIAL ASYMMETRY 1 0.0010
97 DISSOCIATION 8 0.0010
98 ALCOHOL INTERACTION 2 0.0010
99 PSYCHOTIC DISORDER 30 0.0010
100 ENURESIS 4 0.0010
101 SCHIZOPHRENIA 12 0.0010
102 TONGUE BITING 2 0.0010
103 FEELING DRUNK 7 0.0009
104 INCREASED APPETITE 18 0.0009
105 OCULOGYRIC CRISIS 2 0.0009
106 WITHDRAWAL SYNDROME 39 0.0009
107 BIPOLAR I DISORDER 2 0.0009
108 NEAR DEATH EXPERIENCE 3 0.0009
109 STRESS AT WORK 1 0.0009
110 METABOLIC SURGERY 1 0.0009
111 DRUG WITHDRAWAL SYNDROME 77 0.0009
112 CARBON DIOXIDE DECREASED 1 0.0009
113 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
114 ALLODYNIA 1 0.0009
115 DISTURBANCE IN SOCIAL BEHAVIOUR 2 0.0008
116 WEIGHT ABNORMAL 2 0.0008
117 SLOW SPEECH 2 0.0008
118 IMPULSIVE BEHAVIOUR 3 0.0008
119 SOMNAMBULISM 5 0.0008
120 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
121 BODY MASS INDEX INCREASED 1 0.0007
122 SIALOADENITIS 1 0.0007
123 TIC 4 0.0007
124 DROOLING 5 0.0007
125 ERECTION INCREASED 3 0.0007
126 JOINT INSTABILITY 1 0.0007
127 ENDOTRACHEAL INTUBATION 2 0.0007
128 AUDITORY DISORDER 1 0.0007
129 BLOOD ELECTROLYTES DECREASED 1 0.0007
130 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
131 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
132 DARK CIRCLES UNDER EYES 1 0.0007
133 PSYCHIATRIC SYMPTOM 5 0.0007
134 EXCESSIVE EYE BLINKING 1 0.0007
135 TOBACCO USER 1 0.0007
136 NEUROLEPTIC MALIGNANT SYNDROME 8 0.0007
137 MOUTH INJURY 1 0.0007
138 INAPPROPRIATE AFFECT 1 0.0006
139 RESTLESSNESS 23 0.0006
140 GLYCOSYLATED HAEMOGLOBIN DECREASED 1 0.0006
141 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
142 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
143 TOXIC ENCEPHALOPATHY 3 0.0006
144 FOOD AVERSION 1 0.0006
145 SEIZURE LIKE PHENOMENA 1 0.0006
146 LAZINESS 1 0.0006
147 TACHYPHRENIA 2 0.0006
148 BRAIN FOG 9 0.0006
149 CATATONIA 3 0.0006
150 FOOD CRAVING 3 0.0006
151 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
152 DRUG WITHDRAWAL CONVULSIONS 1 0.0006
153 SCHIZOAFFECTIVE DISORDER 1 0.0006
154 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
155 OBSESSIVE THOUGHTS 1 0.0006
156 INTENTIONAL UNDERDOSE 4 0.0005
157 HYPOMANIA 2 0.0005
158 OESOPHAGEAL SPASM 1 0.0005
159 DISORGANISED SPEECH 1 0.0005
160 AURA 1 0.0005
161 PERIORBITAL SWELLING 3 0.0005
162 NARCOLEPSY 1 0.0005
163 OESOPHAGEAL ULCER 2 0.0005
164 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
165 DELUSION 8 0.0005
166 EARLY SATIETY 1 0.0005
167 AKATHISIA 7 0.0005
168 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
169 POLYDIPSIA 2 0.0005
170 HYPERPHAGIA 2 0.0005
171 EJACULATION FAILURE 1 0.0005
172 MUSCLE TIGHTNESS 8 0.0005
173 MUSCLE TWITCHING 11 0.0005
174 SLEEP TERROR 2 0.0005
175 TORTICOLLIS 1 0.0005
176 HEPATIC PAIN 2 0.0005
177 THERAPEUTIC RESPONSE UNEXPECTED 21 0.0005
178 PRODUCT DISPENSING ISSUE 2 0.0005
179 ALCOHOLISM 2 0.0005
180 EXOPHTHALMOS 1 0.0005
181 DEREALISATION 1 0.0005
182 INCOHERENT 3 0.0005
183 GASTRIC BYPASS 1 0.0005
184 AGITATION 33 0.0004
185 IMPAIRED DRIVING ABILITY 5 0.0004
186 HAEMATOCRIT INCREASED 1 0.0004
187 READING DISORDER 1 0.0004
188 SEXUAL DYSFUNCTION 5 0.0004
189 GASTROINTESTINAL OBSTRUCTION 1 0.0004
190 WRONG DOSE 1 0.0004
191 PRESCRIBED OVERDOSE 8 0.0004
192 DYSTONIA 8 0.0004
193 MAJOR DEPRESSION 3 0.0004
194 WEIGHT INCREASED 91 0.0004
195 NIGHTMARE 14 0.0004
196 ACUTE PSYCHOSIS 1 0.0004
197 LETHARGY 23 0.0004
198 DYSPHORIA 2 0.0004
199 ENDODONTIC PROCEDURE 1 0.0004
200 PETIT MAL EPILEPSY 2 0.0004
201 PRODUCT COLOUR ISSUE 2 0.0004
202 DRUG TITRATION ERROR 1 0.0004
203 TRISMUS 2 0.0004
204 RESTLESS LEGS SYNDROME 7 0.0004
205 PERSONALITY DISORDER 1 0.0004
206 AFFECTIVE DISORDER 3 0.0004
207 AGGRESSION 19 0.0004
208 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
209 BLOOD PHOSPHORUS INCREASED 1 0.0004
210 RED BLOOD CELL COUNT INCREASED 1 0.0004
211 URINARY RETENTION 12 0.0004
212 HUNGER 5 0.0004
213 ELECTRIC SHOCK SENSATION 1 0.0004
214 DRUG TOLERANCE DECREASED 1 0.0004
215 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1 0.0004
216 DISORIENTATION 14 0.0004
217 INADEQUATE ANALGESIA 3 0.0004
218 OFF LABEL USE 306 0.0003
219 DYSARTHRIA 13 0.0003
220 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
221 NEGATIVE THOUGHTS 1 0.0003
222 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
223 THIRST 6 0.0003
224 CREPITATIONS 1 0.0003
225 HEAVY MENSTRUAL BLEEDING 3 0.0003
226 METABOLIC ENCEPHALOPATHY 1 0.0003
227 ANGER 11 0.0003
228 GENERALISED OEDEMA 4 0.0003
229 SCOLIOSIS 2 0.0003
230 MIDDLE INSOMNIA 6 0.0003
231 DYSKINESIA 13 0.0003
232 TARDIVE DYSKINESIA 9 0.0003
233 BLEPHAROSPASM 2 0.0003
234 PHOTOPSIA 2 0.0003
235 TESTICULAR PAIN 1 0.0003
236 FEELING JITTERY 6 0.0003
237 PARKINSONISM 3 0.0003
238 SUSPECTED COVID-19 1 0.0003
239 CORONAVIRUS INFECTION 2 0.0003
240 SKIN INJURY 1 0.0003
241 MOTOR DYSFUNCTION 3 0.0003
242 SLUGGISHNESS 3 0.0003
243 SOMNOLENCE 59 0.0003
244 FORMICATION 2 0.0003
245 WEIGHT FLUCTUATION 3 0.0003
246 INSOMNIA 76 0.0003
247 HALLUCINATION, VISUAL 6 0.0003
248 DEPRESSIVE SYMPTOM 1 0.0003
249 THERMAL BURN 2 0.0003
250 FIBRIN D DIMER INCREASED 1 0.0003
251 ALCOHOL USE 1 0.0003
252 URINARY INCONTINENCE 8 0.0003
253 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
254 BONE DENSITY ABNORMAL 1 0.0003
255 SNORING 1 0.0003
256 OESOPHAGEAL DISORDER 1 0.0003
257 TREMOR 43 0.0003
258 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
259 REHABILITATION THERAPY 1 0.0003
260 PANIC DISORDER 1 0.0003
261 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
262 FEELING ABNORMAL 61 0.0003
263 OESOPHAGEAL PAIN 1 0.0003
264 HALLUCINATION 19 0.0003
265 EXPOSURE VIA BREAST MILK 1 0.0003
266 MUSCLE RIGIDITY 3 0.0003
267 SUBSTANCE ABUSE 2 0.0002
268 WEIGHT DECREASED 68 0.0002
269 SELF-MEDICATION 1 0.0002
270 SOCIAL PROBLEM 1 0.0002
271 SELF-INJURIOUS IDEATION 1 0.0002
272 DRUG USE DISORDER 2 0.0002
273 HYPERPYREXIA 1 0.0002
274 FACIAL PARALYSIS 2 0.0002
275 MYDRIASIS 3 0.0002
276 ERECTILE DYSFUNCTION 6 0.0002
277 DELIRIUM 8 0.0002
278 CHAPPED LIPS 1 0.0002
279 PRODUCT PRESCRIBING ISSUE 5 0.0002
280 DECREASED APPETITE 53 0.0002
281 GRIP STRENGTH DECREASED 2 0.0002
282 PRODUCT COMMUNICATION ISSUE 2 0.0002
283 ILEUS PARALYTIC 1 0.0002
284 ANAL INCONTINENCE 2 0.0002
285 LIP DRY 2 0.0002
286 HAEMOGLOBIN INCREASED 1 0.0002
287 SUICIDAL IDEATION 20 0.0002
288 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
289 ABNORMAL DREAMS 6 0.0002
290 OVARIAN CANCER 2 0.0002
291 LOCALISED OEDEMA 1 0.0002
292 PRODUCT DISTRIBUTION ISSUE 2 0.0002
293 PERSONALITY CHANGE 2 0.0002
294 SUSPECTED SUICIDE 1 0.0002
295 BLOOD PROLACTIN INCREASED 1 0.0002
296 SEASONAL ALLERGY 3 0.0002
297 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
298 SLEEP APNOEA SYNDROME 4 0.0002
299 DRY MOUTH 17 0.0002
300 SEIZURE 24 0.0002
301 HUMERUS FRACTURE 1 0.0002
302 STILLBIRTH 1 0.0002
303 MENTAL DISORDER 9 0.0002
304 MENTAL IMPAIRMENT 5 0.0002
305 APATHY 3 0.0002
306 PHARYNGEAL SWELLING 2 0.0002
307 THERAPY CHANGE 2 0.0002
308 ABNORMAL BEHAVIOUR 8 0.0002
309 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
310 OEDEMA PERIPHERAL 24 0.0002
311 WEIGHT LOSS POOR 1 0.0002
312 CACHEXIA 1 0.0002
313 NYSTAGMUS 1 0.0002
314 FOOD POISONING 1 0.0002
315 DECREASED ACTIVITY 2 0.0002
316 BEHAVIOUR DISORDER 1 0.0002
317 MENSTRUATION DELAYED 2 0.0002
318 BIPOLAR DISORDER 2 0.0002
319 BACK INJURY 2 0.0002
320 BLOOD GLUCOSE FLUCTUATION 2 0.0002
321 NONSPECIFIC REACTION 1 0.0002
322 CONFUSIONAL STATE 29 0.0002
323 DIZZINESS 89 0.0002
324 ANXIETY 50 0.0002
325 PARANOIA 3 0.0002
326 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
327 EXTRA DOSE ADMINISTERED 7 0.0002
328 METABOLIC DISORDER 1 0.0002
329 ELECTROLYTE IMBALANCE 2 0.0002
330 COGNITIVE DISORDER 8 0.0002
331 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
332 SLEEP DISORDER 12 0.0002
333 DECREASED INTEREST 1 0.0002
334 BRADYKINESIA 1 0.0002
335 ATAXIA 2 0.0002
336 PRODUCT PRESCRIBING ERROR 4 0.0002
337 ADVERSE DRUG REACTION 15 0.0002
338 TREATMENT NONCOMPLIANCE 9 0.0002
339 DYSURIA 6 0.0002
340 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
341 THINKING ABNORMAL 3 0.0002
342 MUSCLE ATROPHY 2 0.0002
343 SCREAMING 1 0.0002
344 MOOD SWINGS 5 0.0002
345 GALACTORRHOEA 1 0.0002
346 HYPERHIDROSIS 20 0.0002
347 UNRESPONSIVE TO STIMULI 4 0.0002
348 DIPLOPIA 4 0.0002
349 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
350 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
351 SPEECH DISORDER 8 0.0002
352 DYSGRAPHIA 1 0.0002
353 TOOTH INFECTION 2 0.0002
354 DRUG INTERACTION 24 0.0002
355 UPPER LIMB FRACTURE 3 0.0002
356 BALANCE DISORDER 13 0.0002
357 MENSTRUATION IRREGULAR 4 0.0001
358 POST-TRAUMATIC STRESS DISORDER 1 0.0001
359 INTENTIONAL SELF-INJURY 3 0.0001
360 THERAPEUTIC RESPONSE DECREASED 9 0.0001
361 MOOD ALTERED 4 0.0001
362 EYE MOVEMENT DISORDER 1 0.0001
363 COORDINATION ABNORMAL 2 0.0001
364 SINUS TACHYCARDIA 2 0.0001
365 LIVER FUNCTION TEST INCREASED 3 0.0001
366 PANIC REACTION 1 0.0001
367 HYPOKINESIA 2 0.0001
368 PANIC ATTACK 5 0.0001
369 HOSPITALISATION 21 0.0001
370 VOMITING 64 0.0001
371 IRRITABILITY 8 0.0001
372 PAROSMIA 1 0.0001
373 HEPATIC ENZYME INCREASED 9 0.0001
374 TROPONIN INCREASED 1 0.0001
375 HAEMODYNAMIC INSTABILITY 1 0.0001
376 HYPERTHERMIA 1 0.0001
377 HIP ARTHROPLASTY 2 0.0001
378 BOWEL MOVEMENT IRREGULARITY 1 0.0001
379 FOOD ALLERGY 1 0.0001
380 OEDEMA 7 0.0001
381 SWOLLEN TONGUE 4 0.0001
382 HAEMORRHAGIC STROKE 1 0.0001
383 GASTROINTESTINAL INFLAMMATION 1 0.0001
384 NASAL DISCOMFORT 1 0.0001
385 PNEUMOTHORAX 2 0.0001
386 BLOOD ALBUMIN DECREASED 1 0.0001
387 MUSCULOSKELETAL STIFFNESS 11 0.0001
388 DIABETIC KETOACIDOSIS 3 0.0001
389 SWELLING FACE 8 0.0001
390 POLYURIA 1 0.0001
391 ABNORMAL FAECES 1 0.0001
392 HYPERAESTHESIA 1 0.0001
393 PHOTOSENSITIVITY REACTION 2 0.0001
394 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
395 HYPOAESTHESIA 18 0.0001
396 RHABDOMYOLYSIS 5 0.0001
397 BLOOD MAGNESIUM DECREASED 1 0.0001
398 SKIN SWELLING 1 0.0001
399 VERTIGO 7 0.0001
400 AMENORRHOEA 2 0.0001
401 DEPRESSED MOOD 6 0.0001
402 GASTROINTESTINAL DISORDER 10 0.0001
403 THROAT TIGHTNESS 3 0.0001
404 GAIT DISTURBANCE 21 0.0001
405 MEMORY IMPAIRMENT 15 0.0001
406 TINNITUS 5 0.0001
407 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
408 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22 0.0001
409 UROSEPSIS 1 0.0001
410 MENTAL STATUS CHANGES 3 0.0001
411 ILLNESS 11 0.0001
412 BLOOD SODIUM DECREASED 2 0.0001
413 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
414 GASTRIC ULCER 2 0.0001
415 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
416 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
417 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
418 PERIPHERAL SWELLING 16 0.0001
419 DRUG INTOLERANCE 10 0.0001
420 DIZZINESS POSTURAL 1 0.0001
421 VISION BLURRED 14 0.0001
422 VITREOUS FLOATERS 1 0.0001
423 CONSTIPATION 22 0.0001
424 BLOOD PRESSURE ABNORMAL 2 0.0001
425 HYPOTHERMIA 1 0.0001
426 BODY TEMPERATURE INCREASED 2 0.0001
427 FEELING HOT 6 0.0001
428 EMOTIONAL DISORDER 3 0.0001
429 DEPRESSION 22 0.0001
430 POLLAKIURIA 4 0.0001
431 NERVOUSNESS 5 0.0001
432 ROAD TRAFFIC ACCIDENT 4 0.0001
433 INCONTINENCE 1 0.0001
434 RENAL PAIN 1 0.0001
435 PALPITATIONS 11 0.0001
436 NIGHT SWEATS 3 0.0001
437 POOR QUALITY SLEEP 2 0.0001
438 DISTURBANCE IN ATTENTION 5 0.0001
439 SKIN LACERATION 1 0.0001
440 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
441 GASTROINTESTINAL PAIN 1 0.0001
442 DENTAL CARIES 1 0.0001
443 TOOTH DISORDER 2 0.0001
444 HYPERTENSIVE CRISIS 1 0.0001
445 BLOOD CALCIUM DECREASED 1 0.0001
446 NAUSEA 70 0.0001
447 MICTURITION URGENCY 1 0.0001
448 NEOPLASM 1 0.0001
449 COMA 4 0.0001
450 MYOCLONUS 1 0.0001
451 ACCIDENT 1 0.0001
452 ABDOMINAL DISCOMFORT 14 0.0001
453 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
454 ACCIDENTAL OVERDOSE 3 0.0001
455 ENCEPHALOPATHY 2 0.0001
456 EXTRAPYRAMIDAL DISORDER 2 0.0001
457 TOOTH EXTRACTION 1 0.0001
458 POISONING 1 0.0001
459 HAEMATEMESIS 2 0.0001
460 LOSS OF CONSCIOUSNESS 10 0.0001
461 INTENTIONAL OVERDOSE 5 0.0001
462 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
463 HIATUS HERNIA 1 0.0001
464 MYALGIA 13 0.0001
465 MUSCLE SPASMS 14 0.0001
466 ANHEDONIA 2 0.0001
467 BEDRIDDEN 1 0.0001
468 ANKYLOSING SPONDYLITIS 1 0.0001
469 ADVERSE REACTION 1 0.0001
470 SWELLING 7 0.0001
471 TACHYPNOEA 1 0.0001
472 IMPAIRED GASTRIC EMPTYING 1 0.0001
473 RESPIRATORY ARREST 2 0.0001
474 ANAPHYLACTIC REACTION 4 0.0001
475 FATIGUE 56 0.0001
476 PARAESTHESIA 11 0.0001
477 PARAESTHESIA ORAL 1 0.0001
478 GASTROENTERITIS 1 0.0001
479 DYSSTASIA 2 0.0001
480 MALAISE 30 0.0001
481 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
482 SURGERY 4 0.0001
483 SKIN HAEMORRHAGE 1 0.0001
484 HYPOAESTHESIA ORAL 1 0.0001
485 HEPATIC FAILURE 2 0.0001
486 APHASIA 2 0.0001
487 LACRIMATION INCREASED 2 0.0001
488 DISCOMFORT 4 0.0001
489 ANKLE FRACTURE 1 0.0001
490 BLOOD GLUCOSE INCREASED 12 0.0001
491 DYSPHAGIA 6 0.0001
492 BLOOD GLUCOSE DECREASED 3 0.0001
493 SENSORY DISTURBANCE 1 0.0001
494 MOVEMENT DISORDER 2 0.0001
495 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
496 MUSCULAR WEAKNESS 7 0.0001
497 BACK DISORDER 1 0.0001
498 EXPIRED PRODUCT ADMINISTERED 2 0.0001
499 DRUG ABUSE 5 0.0001
500 GAIT INABILITY 2 0.0001
501 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
502 CEREBROVASCULAR ACCIDENT 10 0.0001
503 FLUID RETENTION 3 0.0001
504 THERAPY CESSATION 3 0.0001
505 GASTRIC DISORDER 2 0.0001
506 MUSCULOSKELETAL DISCOMFORT 1 0.0001
507 ORTHOSTATIC HYPOTENSION 1 0.0001
508 SYRINGE ISSUE 1 0.0001
509 INTENTIONAL PRODUCT MISUSE 5 0.0001
510 COLD SWEAT 1 0.0001
511 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
512 CEREBRAL HAEMORRHAGE 2 0.0001
513 BLOOD GLUCOSE ABNORMAL 1 0.0001
514 FALL 18 0.0001
515 HEPATIC STEATOSIS 1 0.0001
516 NECK PAIN 3 0.0001
517 CARDIAC DISORDER 5 0.0001
518 HEPATIC CIRRHOSIS 1 0.0001
519 UNEVALUABLE EVENT 4 0.0001
520 FRACTURE 1 0.0001
521 DEHYDRATION 7 0.0001
522 DIABETES MELLITUS 4 0.0001
523 SEROTONIN SYNDROME 1 0.0001
524 HAEMORRHOIDS 1 0.0001
525 CHILLS 6 0.0001
526 HEART RATE INCREASED 5 0.0001
527 PREGNANCY 1 0.0000
528 THROMBOSIS 4 0.0000
529 EMOTIONAL DISTRESS 6 0.0000
530 SUICIDE ATTEMPT 3 0.0000
531 TASTE DISORDER 1 0.0000
532 INFLUENZA LIKE ILLNESS 4 0.0000
533 HYPERSENSITIVITY 9 0.0000
534 TREATMENT FAILURE 4 0.0000
535 COMPLETED SUICIDE 4 0.0000
536 DERMATITIS 1 0.0000
537 EATING DISORDER 1 0.0000
538 IMPAIRED WORK ABILITY 1 0.0000
539 AMNESIA 3 0.0000
540 PRODUCT DISPENSING ERROR 1 0.0000
541 STEVENS-JOHNSON SYNDROME 1 0.0000
542 ORAL PAIN 1 0.0000
543 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
544 CHROMATURIA 1 0.0000
545 HEART RATE IRREGULAR 1 0.0000
546 PRODUCT AVAILABILITY ISSUE 1 0.0000
547 BLOOD CHOLESTEROL INCREASED 2 0.0000
548 BURNING SENSATION 3 0.0000
549 PULMONARY EMBOLISM 4 0.0000
550 MIGRAINE 4 0.0000
551 BLOOD PRESSURE FLUCTUATION 1 0.0000
552 LIVER INJURY 1 0.0000
553 AGEUSIA 1 0.0000
554 PNEUMONIA ASPIRATION 1 0.0000
555 HYPOTENSION 8 0.0000
556 HOT FLUSH 3 0.0000
557 PRODUCT COMPLAINT 1 0.0000
558 BLOOD PRESSURE INCREASED 6 0.0000
559 HYPOPHAGIA 1 0.0000
560 ERYTHEMA 8 0.0000
561 INFLAMMATION 2 0.0000
562 SKIN ULCER 1 0.0000
563 RESPIRATORY TRACT INFECTION 1 0.0000
564 DEAFNESS 1 0.0000
565 ECZEMA 2 0.0000
566 JOINT STIFFNESS 1 0.0000
567 BRADYCARDIA 2 0.0000
568 EAR INFECTION 1 0.0000
569 DRUG DEPENDENCE 6 0.0000
570 DIARRHOEA 24 0.0000
571 FEAR 1 0.0000
572 JAUNDICE 1 0.0000
573 PAIN OF SKIN 1 0.0000
574 BLOOD BILIRUBIN INCREASED 1 0.0000
575 PALLOR 1 0.0000
576 CONDITION AGGRAVATED 11 0.0000
577 FEELING COLD 1 0.0000
578 SEPSIS 4 0.0000
579 PANCYTOPENIA 2 0.0000
580 URINARY TRACT INFECTION 6 0.0000
581 INTENTIONAL DOSE OMISSION 1 0.0000
582 RASH 15 0.0000
583 NEEDLE ISSUE 1 0.0000
584 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
585 DYSPHONIA 2 0.0000
586 NASAL CONGESTION 2 0.0000
587 RESPIRATORY DISORDER 1 0.0000
588 BLOOD POTASSIUM DECREASED 1 0.0000
589 HYPERTENSION 7 0.0000
590 CHEST PAIN 6 0.0000
591 PRODUCT USE ISSUE 6 0.0000
592 ASTHENIA 12 0.0000
593 DYSPNOEA 18 0.0000
594 HEAD INJURY 1 0.0000
595 HEADACHE 19 0.0000
596 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
597 LIP SWELLING 1 0.0000
598 SYNCOPE 3 0.0000
599 SKIN DISORDER 1 0.0000
600 TYPE 2 DIABETES MELLITUS 1 0.0000
601 FLUSHING 3 0.0000
602 RASH MACULAR 1 0.0000
603 HYPOXIA 1 0.0000
604 MOBILITY DECREASED 2 0.0000
605 OVERDOSE 6 0.0000
606 CRYING 1 0.0000
607 HYPERGLYCAEMIA 1 0.0000
608 NASOPHARYNGITIS 5 0.0000
609 EYE SWELLING 1 0.0000
610 EPISTAXIS 2 0.0000
611 DYSPNOEA EXERTIONAL 1 0.0000
612 COLITIS 1 0.0000
613 ACUTE KIDNEY INJURY 4 0.0000
614 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
615 DRUG INEFFECTIVE 34 0.0000
616 ALOPECIA 5 0.0000
617 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
618 CARDIAC FAILURE 2 0.0000
619 JOINT SWELLING 3 0.0000
620 BLINDNESS 1 0.0000
621 PAIN 15 0.0000
622 ABDOMINAL PAIN UPPER 5 0.0000
623 CARDIAC ARREST 2 0.0000
624 PRODUCT DOSE OMISSION ISSUE 7 0.0000
625 HYPOACUSIS 1 0.0000
626 PYREXIA 8 0.0000
627 LIVER DISORDER 1 0.0000
628 TACHYCARDIA 2 0.0000
629 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
630 COLITIS ULCERATIVE 1 0.0000
631 PULMONARY OEDEMA 1 0.0000
632 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
633 NEPHROLITHIASIS 1 0.0000
634 ABDOMINAL PAIN 5 0.0000
635 ARRHYTHMIA 1 0.0000
636 OCULAR HYPERAEMIA 1 0.0000
637 PRURITUS 8 0.0000
638 ATRIAL FIBRILLATION 2 0.0000
639 DRY EYE 1 0.0000
640 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
641 DEPENDENCE 1 0.0000
642 THROMBOCYTOPENIA 2 0.0000
643 BLISTER 1 0.0000
644 OXYGEN SATURATION DECREASED 1 0.0000
645 EYE PAIN 1 0.0000
646 DEATH 15 0.0000
647 PRODUCT SUBSTITUTION ISSUE 1 0.0000
648 PAIN IN EXTREMITY 5 0.0000
649 WHEEZING 1 0.0000
650 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
651 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
652 VISUAL IMPAIRMENT 2 0.0000
653 RHINORRHOEA 1 0.0000
654 INJURY 1 0.0000
655 SKIN BURNING SENSATION 1 0.0000
656 DYSGEUSIA 1 0.0000
657 ACNE 1 0.0000
658 BACK PAIN 3 0.0000
659 ARTHRITIS 1 0.0000
660 PNEUMONIA 4 0.0000
661 ARTHRALGIA 5 0.0000
662 RENAL IMPAIRMENT 1 0.0000
663 TOXICITY TO VARIOUS AGENTS 2 0.0000
664 SKIN EXFOLIATION 1 0.0000
665 PRODUCT STORAGE ERROR 1 0.0000
666 NO ADVERSE EVENT 2 0.0000
667 ADVERSE EVENT 1 0.0000
668 COUGH 3 0.0000
669 CONTUSION 1 0.0000
670 DYSPEPSIA 1 0.0000
671 CHEST DISCOMFORT 1 0.0000
672 SINUSITIS 1 0.0000
673 INCORRECT DOSE ADMINISTERED 2 0.0000
674 RENAL FAILURE 1 0.0000
675 INFECTION 1 0.0000
676 INJECTION SITE PAIN 2 0.0000
677 URTICARIA 1 0.0000
678 COVID-19 1 0.0000
679 ANAEMIA 1 0.0000